All In MedTech

510(k) device

Glean Urodynamics System Male Delivery System (GUS-1000-M)

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

2

510(k) pathway

Device trials

5

Naming "Glean Urodynamics"

MAUDE reports

0

Brand "Glean Urodynamics", since 2015

PubMed studies

3

Mentioning "Glean Urodynamics"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Glean Urodynamics System Male Delivery System (GUS-1000-M)

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 2 of 2 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "Glean Urodynamics", any status and sponsor, newest update first.

Open in Trial Radar
  • Bright UroNot on our public-company list

    NCT07485205 · 72 participants (planned) · Start Mar 31, 2026 · Primary completion Mar 2027

    Device: Glean Urodynamics System · For: Lower Urinary Tract Symptoms (LUTS)

    Sites: Phoenix, Arizona; Tucson, Arizona; Tustin, California

  • Bright UroNot on our public-company list

    NCT07425015 · 101 participants (planned) · Start Feb 17, 2026 · Primary completion Jun 2027

    Device: Glean Urodynamics System · For: Urology; Urinary Bladder, Overactive; Benign Prostatic Hyperplasia and 4 more

    Sites: New Orleans, Louisiana; Hanover, Maryland; Owings Mills, Maryland · 9 sites in all

  • Bright UroNot on our public-company list

    NCT05694793 · 30 participants · Start Jun 3, 2025 · Primary completion Jul 27, 2026

    Device: Glean Urodynamics System; Glean Urodynamics System · For: Urologic Diseases; Urodynamics

    Sites: Murrieta, California; San Diego, California; Cleveland, Ohio

2 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Glean Urodynamics", and for the whole product code for context.

This brand

0 reports: 0 malfunction, 0 injury, 0 death

Whole product code EXQ

1 reports: 1 malfunction, 0 injury, 0 death

Newest reports for this brand

No MAUDE reports name this brand.

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recall in FDA's data is linked to these FDA numbers.

Published research

The most relevant PubMed records for "Glean Urodynamics"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.